Hypertention
Conditions
Interventions
treatment group:Songlingxuemaikang Capsule
control group:placebo
Sponsors
Xi Yuan Hospital, China Academy of Chinese Medicine Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Primary hypertension, grade 1, in low and middle risk; 2. Patients have not taken or not regularly taken antihypertensive drugs; 3. Aged 20 to 75 years; 4. Patients are informed about the trial and voluntarilysign the consent form.
Exclusion criteria
Exclusion criteria: 1. Serious liver disease or alanine transaminase(ALT)/aspartate transaminase(AST) values higher than the upper reference limit value; 2. Severe mental illness, serious diseases of the hematopoietic system, malignancy or having a life expectancy less than 3 years; 3. Suspected to be poor compliance or follow-up; 4. Pregnant women or women who are preparing for pregnancy, lactating women; 5. Previous involvement in other clinical trials or participation in other clinical trials within the past3 months; 6. subjects who are known to be allergic to ingredients of the study drug; 7. Allergies or multiple drug allergies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 24 hours average blood pressure; | — |
Secondary
| Measure | Time frame |
|---|---|
| Daytime average blood pressure;nocturnal average blood pressure;nocturnal average blood pressure;Blood pressure fluctuation; | — |
Countries
China
Contacts
Public ContactShi Dazhuo
Xi Yuan Hospital, China Academy of Chinese Medicine Sciences
Outcome results
None listed